Lipid and glycolipid antigens of CD1d-restricted natural killer T cells

Manjunatha M. Venkataswamy, Steven A. Porcelli

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

In spite of their relatively limited antigen receptor repertoire, CD1d-restricted NKT cells recognize a surprisingly diverse range of lipid and glycolipid antigens. Recent studies of natural and synthetic CD1d-presented antigens provide an increasingly detailed picture of how the specific structural features of these lipids and glycolipids influence their ability to be presented to NKT cells and stimulate their diverse immunologic functions. Particularly for synthetic analogues of α-galactosylceramides which have been the focus of intense recent investigation, it is becoming clear that the design of glycolipid antigens with the ability to precisely control the specific immunologic activities of NKT cells is likely to be feasible. The emerging details of the mechanisms underlying the structure-activity relationship of NKT cell antigens will assist greatly in the design and production of immunomodulatory agents for the precise manipulation of NKT cells and the many other components of the immune system that they influence.

Original languageEnglish (US)
Pages (from-to)68-78
Number of pages11
JournalSeminars in Immunology
Volume22
Issue number2
DOIs
StatePublished - Apr 2010

Fingerprint

CD1d Antigen
Natural Killer T-Cells
Glycolipids
Lipids
Antigens
Galactosylceramides
Synthetic Vaccines
Antigen Receptors
Structure-Activity Relationship
Immune System

Keywords

  • α-Galactosylceramide
  • Antigen presentation
  • CD1d
  • Glycolipid
  • Natural killer T cell

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. / Venkataswamy, Manjunatha M.; Porcelli, Steven A.

In: Seminars in Immunology, Vol. 22, No. 2, 04.2010, p. 68-78.

Research output: Contribution to journalArticle

@article{d90d8511f451409ca88228e7deede938,
title = "Lipid and glycolipid antigens of CD1d-restricted natural killer T cells",
abstract = "In spite of their relatively limited antigen receptor repertoire, CD1d-restricted NKT cells recognize a surprisingly diverse range of lipid and glycolipid antigens. Recent studies of natural and synthetic CD1d-presented antigens provide an increasingly detailed picture of how the specific structural features of these lipids and glycolipids influence their ability to be presented to NKT cells and stimulate their diverse immunologic functions. Particularly for synthetic analogues of α-galactosylceramides which have been the focus of intense recent investigation, it is becoming clear that the design of glycolipid antigens with the ability to precisely control the specific immunologic activities of NKT cells is likely to be feasible. The emerging details of the mechanisms underlying the structure-activity relationship of NKT cell antigens will assist greatly in the design and production of immunomodulatory agents for the precise manipulation of NKT cells and the many other components of the immune system that they influence.",
keywords = "α-Galactosylceramide, Antigen presentation, CD1d, Glycolipid, Natural killer T cell",
author = "Venkataswamy, {Manjunatha M.} and Porcelli, {Steven A.}",
year = "2010",
month = "4",
doi = "10.1016/j.smim.2009.10.003",
language = "English (US)",
volume = "22",
pages = "68--78",
journal = "Seminars in Immunology",
issn = "1044-5323",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Lipid and glycolipid antigens of CD1d-restricted natural killer T cells

AU - Venkataswamy, Manjunatha M.

AU - Porcelli, Steven A.

PY - 2010/4

Y1 - 2010/4

N2 - In spite of their relatively limited antigen receptor repertoire, CD1d-restricted NKT cells recognize a surprisingly diverse range of lipid and glycolipid antigens. Recent studies of natural and synthetic CD1d-presented antigens provide an increasingly detailed picture of how the specific structural features of these lipids and glycolipids influence their ability to be presented to NKT cells and stimulate their diverse immunologic functions. Particularly for synthetic analogues of α-galactosylceramides which have been the focus of intense recent investigation, it is becoming clear that the design of glycolipid antigens with the ability to precisely control the specific immunologic activities of NKT cells is likely to be feasible. The emerging details of the mechanisms underlying the structure-activity relationship of NKT cell antigens will assist greatly in the design and production of immunomodulatory agents for the precise manipulation of NKT cells and the many other components of the immune system that they influence.

AB - In spite of their relatively limited antigen receptor repertoire, CD1d-restricted NKT cells recognize a surprisingly diverse range of lipid and glycolipid antigens. Recent studies of natural and synthetic CD1d-presented antigens provide an increasingly detailed picture of how the specific structural features of these lipids and glycolipids influence their ability to be presented to NKT cells and stimulate their diverse immunologic functions. Particularly for synthetic analogues of α-galactosylceramides which have been the focus of intense recent investigation, it is becoming clear that the design of glycolipid antigens with the ability to precisely control the specific immunologic activities of NKT cells is likely to be feasible. The emerging details of the mechanisms underlying the structure-activity relationship of NKT cell antigens will assist greatly in the design and production of immunomodulatory agents for the precise manipulation of NKT cells and the many other components of the immune system that they influence.

KW - α-Galactosylceramide

KW - Antigen presentation

KW - CD1d

KW - Glycolipid

KW - Natural killer T cell

UR - http://www.scopus.com/inward/record.url?scp=77649231838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649231838&partnerID=8YFLogxK

U2 - 10.1016/j.smim.2009.10.003

DO - 10.1016/j.smim.2009.10.003

M3 - Article

C2 - 19945296

AN - SCOPUS:77649231838

VL - 22

SP - 68

EP - 78

JO - Seminars in Immunology

JF - Seminars in Immunology

SN - 1044-5323

IS - 2

ER -